Sulfonylureas mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Sulfonylureas Mechanism of Action: Insulin Secretion Stimulation
Sulfonylureas are a class of oral antidiabetic drugs that primarily work by stimulating insulin secretion from pancreatic beta cells. They achieve this by binding to the sulfonylurea receptor (SUR) on the beta-cell plasma membrane, which is part of the ATP-sensitive potassium (KATP) channel complex. When sulfonylureas bind to this receptor, they cause the KATP channels to close, leading to cell membrane depolarization. This depolarization opens voltage-dependent calcium channels, allowing calcium to enter the cell, which then triggers the exocytosis of insulin-containing granules and increases insulin release into the bloodstream 2458+2 MORE.
Sulfonylurea Receptor and KATP Channel Inhibition
The sulfonylurea receptor is a member of the traffic ATPase family and contains two intracellular nucleotide binding folds. The binding of sulfonylureas to this receptor is essential for their hypoglycemic effect, as it mediates the closure of KATP channels and subsequent insulin secretion. Mutations in the sulfonylurea receptor gene can lead to disorders such as familial hyperinsulinism, highlighting the importance of this receptor in glucose regulation .
Additional Mechanisms: Protein Kinase C and Exocytosis
Beyond the classic KATP channel pathway, sulfonylureas can also enhance insulin exocytosis through mechanisms that may involve protein kinase C (PKC). Some studies suggest that sulfonylureas promote exocytosis by interacting with the secretory machinery in a PKC-dependent manner, although this does not involve direct activation of PKC itself 45. This additional pathway may contribute to the overall hypoglycemic action of sulfonylureas.
Extra-Pancreatic Effects: Insulin Sensitization and Glucose Metabolism
Sulfonylureas also have extra-pancreatic effects. They can enhance the sensitivity of peripheral tissues to insulin, reduce hepatic insulin clearance, and decrease glucagon secretion. These actions help improve glucose uptake by tissues and reduce glucose production by the liver, further contributing to their antidiabetic effects 1679.
Recent research has shown that sulfonylureas can inhibit phosphorylation of peroxisome proliferator-activated receptor gamma (PPARγ) at Ser-273 in adipocytes. This action is associated with improved insulin sensitivity and a favorable expression profile of adipokines, suggesting that sulfonylureas may have direct insulin-sensitizing effects on adipose tissue, in addition to their pancreatic actions .
Summary of Sulfonylureas’ Multifaceted Mechanism
In summary, sulfonylureas lower blood glucose primarily by stimulating insulin secretion through inhibition of KATP channels in pancreatic beta cells. They also enhance insulin exocytosis via PKC-dependent pathways and exert extra-pancreatic effects by improving insulin sensitivity and modulating glucose metabolism in peripheral tissues. These combined actions make sulfonylureas effective agents for managing type 2 diabetes, though their use must be balanced with the risk of hypoglycemia and other side effects 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic
Sulfonylurea receptors and mechanism of sulfonylurea action.
Sulfonylureas stimulate insulin release by binding to the sulfonylurea receptor in beta-cells, which mediates insulin release and may contribute to adverse effects in the cardiovascular and central nervous systems.
DOI